Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:40 PM
Ignite Modification Date:
2025-12-24 @ 3:40 PM
NCT ID:
NCT01230892
Eligibility Criteria:
Inclusion Criteria:
* Patients with stable angina or acute coronary syndrome
* Moderate coronary lesion (defined as a lesion significant enough by the treating physician to warrant further evaluation using CFR or FFR or intravascular ultrasound assessment).
* Lesion located in the proximal 60mm of the RCA or LAD.
* On stable medical therapy for other cardiac risk factors.
Exclusion Criteria:
* Left Main lesion greater than 50% stenosis
* Patients with a history of coronary artery bypass surgery
* Severe valvular heart disease
* Patients presenting with a STEMI.
* Inability to provide informed consent prior to randomization
* Creatinine \>1.5
* Lesions located beyond 60mm in an epicardial vessel
* Coronary anatomy requiring CABG
* B-blocker, calcium channel blocker or extended-release nitrate therapy within last 48 hours.
* Bradycardia (HR\<50 bpm)
* Hypotension (SBP\<100mmHg)
* Severe COPD by pulmonary function testing
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
21 Years
Maximum Age:
79 Years
Study:
NCT01230892
Study Brief:
Protocol Section:
NCT01230892